TP53 and invasive breast carcinoma: Compared to this group, the loss of function of p53 resulted in an expected, based on our knowledge of Li Fraumani Syndrome [45], nearly 7-fold increase in cumulative risk of invasive breast cancer, 24.6 (range 19.8 to 29.4)%, by the age of 55 (Figure 6).